Vi bygger
Sveriges bästa
Private Banking

On Wednesday 10 December 2025, Dellia Group ASA (“Dellia”) announced the successful completion of a private placement of 650,000 new shares at a fixed price of NOK 310 per share, generating gross proceeds of NOK 201.5 million. The private placement attracted strong interest and was multiple times covered. Proceeds from the private placement will be used to fund Dellia’s acquisition of Kirirom Food Production (K.F.P.) Co., LTD (“Kirirom”), its largest and most significant supplier of dried fruit products.

Dellia is a Nordic consumer goods group with a fast-growing position in the dried fruit category. The Group develops and markets brands such as Sunshine Delights®, Dippies® and A Date With® – exciting and tasty products broadening the dried fruit category through mass market appeal.

ABG Sundal Collier appreciates the opportunity to assist Dellia once again after the very successful IPO in September 2025 where we acted as lead manager and sole bookrunner.

WS WeSports Group AB (publ), the leading Nordic specialist in sports and leisure equipment, has successfully completed its IPO on Nasdaq First North Premier Growth Market. The offering, including the greenshoe option, amounted to approximately SEK 500m and was multiple times oversubscribed, driven by strong demand from both new and existing Swedish and international institutional investors.

The Company intends to use the primary proceeds to accelerate growth, primarily by financing selective platform and add-on acquisitions, as well as for investments within existing portfolio companies and general corporate purposes. DNB Asset Management, Handelsbanken Fonder and Svea Bank AB acted as cornerstone investors in the transaction. Cornerstone investors agreed to subscribe for shares in the offering of up to approximately SEK 150m, corresponding to c. 30% of the total offering. The IPO was priced at SEK 80 per share, implying a market capitalization of approximately SEK 2.2bn. Trading in the Company’s shares commenced on 9 December 2025 under the ticker WSG.

Axcel has partnered up with Bekk Consulting, after acquiring the company from TietoEvry, with management team and employees co-investing alongside Axcel. The transaction marks Bekk’s transition to an independent, Axcel-backed company with a strong platform for continued growth. The associated inaugural bond issue attracted strong interest from institutional investors and was significantly oversubscribed, securing the financing required to enable a seamless carve-out.

Bekk is a leading Norwegian technology and management consultancy with more than 600 employees across offices in Oslo and Trondheim. The company provides integrated digital product development and management consulting services, delivering mission-critical digital solutions to blue-chip public and private clients.

ABG Sundal Collier acted as Axcel’s financial advisor in the acquisition of Bekk and subsequently as Joint Bookrunner on the NOK 700 million senior secured bond issue. Net proceeds from the bond, together with equity from Axcel and management, will be used to finance the acquisition and for general corporate purposes.

On Tuesday 9 December 2025, Pensana announced that it has concluded a USD 100 million subscription for new ordinary shares by a strategic investor in support of the company’s U.S. Mine-to-Magnet strategy. Net proceeds from the private placement will be used for development and expansion of the Longonjo rare earth mine in Angola, as well as for downstream investments ahead of the Nasdaq listing in 2026.

Pensana is an LSE listed company with a market capitalisation of USD 425 million (pre-money), establishing a U.S. Mine-to-Magnet supply chain in partnership with eVAC Magnetics in South Carolina with backing from the U.S. Government. The Longonjo mine in Angola is the largest undeveloped rare earth mine globally, and is expected to commence production in early 2027, generating an average life-of-mine EBITDA of USD 263 million p.a. and a project payback of 2 years.

ABGSC thanks Pensana for the opportunity to partner as sole financial advisor and intermediary in connection with the transaction.

On 5 December 2025, Oncoinvent announced the EGM approval of its fully underwritten rights issue of 260 million new shares in the company, raising gross proceeds of NOK 130 million. Oncoinvent is a clinical-stage biotechnology company developing novel radiopharmaceutical therapies against cancer. The lead product candidate, Radspherin®, uses the alpha-emitting radionuclide radium-224, directly targeting micro-metastases in the peritoneum post-surgery, harnessing the benefits of modern radiopharmaceuticals without the complexities of biological targeting. ABG Sundal Collier also advised Oncoinvent earlier this year in its merger with BerGenBio, adding approximately NOK 45 million to the company’s cash runway and securing an uplisting to Euronext Oslo Børs. ABG Sundal Collier acted as joint lead manager and joint bookrunner in the rights issue.

On Wednesday 3 December 2025, Kistefos AS completed the issuance of a new NOK 1,500 million senior unsecured bond with a framework of up to NOK 2,000 million. The net proceeds from the bond issue will be used to refinance KIST09 PRO. The transaction received strong interest and was upsized from the initial amount of NOK 1,000 million.

Kistefos is a private investment company wholly owned by Christen Sveaas with major investments in financial services, telecommunications, IT, logistics, offshore services, commercial real estate development, as well as various financial investments.

We are proud to once again partner with Kistefos in connection with their bond issue and thank them for the vote of confidence